Literature DB >> 18627246

Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.

Rui Duan1, Rory D de Vries, Albert D M E Osterhaus, Lies Remeijer, Georges M G M Verjans.   

Abstract

The prevalence and molecular characteristics of isolates from 173 immunocompetent patients with herpetic keratitis (HK) who were infected with acyclovir (ACV)-resistant (ACV(R)) corneal herpes simplex virus (HSV)-1 was determined. Isolates from 11 (6.4%) of the patients were ACV(R), and 9 of these 11 patients were refractory to therapy with ACV; the ACV(R) isolates from 5 and 1 of these 9 patients were cross-resistant to gancyclovir and to both gancyclovir and foscarnet, respectively. Of the 11 ACV(R) isolates, 10 had, in the thymidine kinase gene, mutations that presumably conferred the ACV(R) phenotype. These data demonstrate a relatively high prevalence of corneal HSV-1 ACV(R) isolates in patients with HK, which emphasizes the need to monitor for ACV susceptibility in patients with HK who are refractory to therapy with ACV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627246     DOI: 10.1086/590668

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

Review 1.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice.

Authors:  Hui-Wen Yao; Shih-Heng Chen; Ching Li; Yuk-Ying Tung; Shun-Hua Chen
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.

Authors:  John E Tavis; Hong Wang; Ann E Tollefson; Baoling Ying; Maria Korom; Xiaohong Cheng; Feng Cao; Katie L Davis; William S M Wold; Lynda A Morrison
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

4.  Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils.

Authors:  Derek J Royer; Min Zheng; Christopher D Conrady; Daniel J J Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

5.  Successful Management of Herpes Simplex Keratitis With Oral Valganciclovir in Patients Unresponsive or Allergic to Conventional Antiviral Therapy.

Authors:  Neslihan Dilruba Koseoglu; Benjamin R Strauss; Pedram Hamrah
Journal:  Cornea       Date:  2019-06       Impact factor: 2.651

6.  Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.

Authors:  Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Ravinder Earla; Suman Sirimulla; Jake Brain Bailey; Dhananjay Pal; Ashim K Mitra
Journal:  Pharm Res       Date:  2013-05-09       Impact factor: 4.200

7.  Inhibitors of signal peptide peptidase (SPP) affect HSV-1 infectivity in vitro and in vivo.

Authors:  Sariah J Allen; Kevin R Mott; Homayon Ghiasi
Journal:  Exp Eye Res       Date:  2014-04-24       Impact factor: 3.467

8.  Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.

Authors:  Chih-Yu Huang; Hui-Wen Yao; Li-Chiu Wang; Fang-Hsiu Shen; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

9.  CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.

Authors:  Devin M West; Chelsea R Del Rosso; Xiao-Tang Yin; Patrick M Stuart
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

10.  Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.

Authors:  Monica M Sauter; Joshua J L Gauger; Curtis R Brandt
Journal:  Antiviral Res       Date:  2014-07-01       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.